WASHINGTON — President Donald Trump is reportedly considering a policy proposal that would reclassify marijuana, psilocybin, and fentanyl under federal drug scheduling laws, according to sources familiar with internal discussions.
The substances are currently listed under Schedule I of the Controlled Substances Act, a category reserved for drugs deemed to have a high potential for abuse and no accepted medical use. The reported proposal would move them to Schedule III, a classification that acknowledges potential medical applications while still maintaining regulatory controls.